Loading…
Serum Choice Influences Lipid Accumulation and Cell Viability in Fatty Acid Treated Immortalised Hepatocytes and Hepatic Stellate Cells
[...]to test if there was interference from lipophilic materials contained in the serum, the SCM was either replenished, replaced with CSM, or replaced with SFM, and cells cultured for 16hrs in the fresh media prior to 6 h or 24 h fatty acid treatment (0-500μM, 1:1 oleic acid: palmitic acid). [...]n...
Saved in:
Published in: | Proceedings of the Nutrition Society 2020, Vol.79 (OCE3), Article E751 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]to test if there was interference from lipophilic materials contained in the serum, the SCM was either replenished, replaced with CSM, or replaced with SFM, and cells cultured for 16hrs in the fresh media prior to 6 h or 24 h fatty acid treatment (0-500μM, 1:1 oleic acid: palmitic acid). [...]no differences in viability were detected between cells cultured in CSM compared to SCM.Fatty acid treatment led to dose-dependent intracellular lipid accumulation in both cell lines, however, effects from serum were observed. Using CSM for vitamin D and fatty acid cotreatment, ongoing experiments are examining mRNA, protein, and microRNA expression in hepatocytes and HSCs in response to vitamin D and lipid loading cotreatment. 1. |
---|---|
ISSN: | 0029-6651 1475-2719 |
DOI: | 10.1017/S0029665120007375 |